Treatment Satisfaction Among Patients Using Anti-Inflammatory Topical Medications for Dry Eye Disease

por White, Darrell E, Zhao, Yang, Jayapalan, Hemalatha, Machiraju, Pattabhi, Periyasamy, Ramu, Ogundele, Abayomi
Publicado 2020

Physician Satisfaction with Anti-Inflammatory Topical Medications for the Treatment of Dry Eye Disease

por White, Darrell E, Zhao, Yang, Jayapalan, Hemalatha, Machiraju, Pattabhi, Periyasamy, Ramu, Ogundele, Abayomi
Publicado 2020

Matching-adjusted indirect comparison of phase 3 clinical trial outcomes of OC-01 (varenicline solution) nasal spray and lifitegrast 5% ophthalmic solution for the treatment of dry...

por White, Darrell E, Hendrix, Laura H, Sun, Lucille, Tam, Iris, Macsai, Marian, Gibson, Andrea A
Publicado 2023

Real-World Treatment Patterns Of Cyclosporine Ophthalmic Emulsion And Lifitegrast Ophthalmic Solution Among Patients With Dry Eye

por White, Darrell E, Zhao, Yang, Ogundele, Abayomi, Fulcher, Nicole, Acs, Annabel, Moore-Schiltz, Laura, Karpecki, Paul M
Publicado 2019

P982: EFFICACY AND SAFETY OF 40 MG VS 60 MG OF ONCE WEEKLY SELINEXOR IN COMBINATION WITH POMALIDOMIDE AND DEXAMETHASONE IN RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA (RRMM)

por White, Darrell, Baljevic, Muhamed, Schiller, Gary, Lentzsch, Suzanne, Chubar, Evgeni, Lavi, Noa, Van Domelen, Dane, Bentur, Ohad, Madan, Sumit
Publicado 2023

Pharmacokinetics and safety of carfilzomib in patients with relapsed multiple myeloma and end-stage renal disease (ESRD): an open-label, single-arm, phase I study

por Quach, Hang, White, Darrell, Spencer, Andrew, Ho, P. Joy, Bhutani, Divaya, White, Mike, Inamdar, Sandeep, Morris, Chris, Ou, Ying, Gyger, Martin
Publicado 2017

Safety and efficacy of amniotic cytokine extract in the treatment of dry eye disease

por Yeu, Elizabeth, Goldberg, Damien F, Mah, Francis S, Beckman, Kenneth A, Luchs, Jodi I, Solomon, Jonathan D, White, Darrell E, Gupta, Preeya K
Publicado 2019

Continuous lenalidomide and low‐dose dexamethasone in patients with transplant‐ineligible newly diagnosed MM: FIRST trial subanalysis of Canadian/US patients

por Belch, Andrew, Bahlis, Nizar, White, Darrell, Cheung, Matthew, Chen, Christine, Shustik, Chaim, Song, Kevin, Tosikyan, Axel, Dispenzieri, Angela, Anderson, Kenneth, Brown, Diane, Robinson, Suzanne, Srinivasan, Shankar, Facon, Thierry
Publicado 2020

Sequential Use of Carfilzomib and Pomalidomide in Relapsed Multiple Myeloma: A Report from the Canadian Myeloma Research Group (CMRG) Database

por McCurdy, Arleigh, Venner, Christopher P., Masih-Khan, Esther, Louzada, Martha, LeBlanc, Richard, Sebag, Michael, Song, Kevin, Jimenez-Zepeda, Victor H., Kotb, Rami, Kardjadj, Moustafa, Mian, Hira, White, Darrell, Stakiw, Julie, Aslam, Muhammad, Reiman, Anthony, Gul, Engin, Reece, Donna
Publicado 2022

Real‐world data on lenalidomide dosing and outcomes in patients newly diagnosed with multiple myeloma: Results from the Canadian Myeloma Research Group Database

por Mian, Hira, LeBlanc, Richard, Louzada, Martha, Masih‐Khan, Esther, McCurdy, Arleigh, Venner, Christopher P., Stakiw, Julie, Kardjadj, Moustafa, Jimenez‐Zepeda, Victor H., Sebag, Michael, White, Darrell, Aslam, Muhammad, Song, Kevin, Reiman, Anthony, Kotb, Rami, Gul, Engin, Reece, Donna
Publicado 2022

The survival impact of maintenance lenalidomide: an analysis of real-world data from the Canadian Myeloma Research Group national database

por Cherniawsky, Hannah M., Kukreti, Vishal, Reece, Donna, Masih-Khan, Esther, McCurdy, Arleigh, Jimenez-Zepeda, Victor H., Sebag, Michael, Song, Kevin, White, Darrell, Stakiw, Julie, LeBlanc, Richard, Reiman, Anthony, Aslam, Muhammad, Louzada, Martha, Kotb, Rami, Gul, Engin, Atenafu, Eshetu, Venner, Christopher P.
Publicado 2020

Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse

por Dimopoulos, Meletios, Weisel, Katja, Moreau, Philippe, Anderson, Larry D., White, Darrell, San-Miguel, Jesus, Sonneveld, Pieter, Engelhardt, Monika, Jenner, Matthew, Corso, Alessandro, Dürig, Jan, Pavic, Michel, Salomo, Morten, Casal, Eva, Srinivasan, Shankar, Yu, Xin, Nguyen, Tuong Vi, Biyukov, Tsvetan, Peluso, Teresa, Richardson, Paul
Publicado 2020

Carfilzomib usage patterns and outcomes in patients with relapsed multiple myeloma: A multi‐institutional report from the Canadian Myeloma Research Group (CMRG) Database

por McCurdy, Arleigh, Louzada, Martha, Venner, Christopher P., Visram, Alissa, Masih‐Khan, Esther, Kardjadj, Moustafa, Jimenez‐Zepeda, Victor H., LeBlanc, Richard, Sebag, Michael, Song, Kevin, White, Darrell, Mian, Hira, Stakiw, Julie, Reiman, Anthony, Aslam, Muhammad, Kotb, Rami, Gul, Engin, Reece, Donna
Publicado 2022

Abstracts of the Cell Therapy Transplant Canada 2022 Annual Conference

por Maier, Stephanie A., Berg, Tobias, Berrigan, Susan, Bramson, Jonathan, Bredeson, Chris, Cantin, Guy, Daly, Andrew, Davies, Gwynivere A., Elsawy, Mahmoud, Garcia-Horton, Alejandro, Lam, Wilson, Lapworth, Alix, Lepic, Kylie, Melo Garcia, Luciana, Schultz, Kirk R., Vasudevan Nampoothiri, Ram, White, Darrell, Delisle, Jean-Sébastien
Publicado 2022

Daratumumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: extended follow-up of POLLUX, a randomized, open-label, phase 3 study

por Bahlis, Nizar J., Dimopoulos, Meletios A., White, Darrell J., Benboubker, Lotfi, Cook, Gordon, Leiba, Merav, Ho, P. Joy, Kim, Kihyun, Takezako, Naoki, Moreau, Philippe, Kaufman, Jonathan L., Krevvata, Maria, Chiu, Christopher, Qin, Xiang, Okonkwo, Linda, Trivedi, Sonali, Ukropec, Jon, Qi, Ming, San-Miguel, Jesus
Publicado 2020

Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis

por McCurdy, Arleigh, Mian, Hira, LeBlanc, Richard, Jimenez-Zepeda, Victor H., Su, Jiandong, Masih-Khan, Esther, Visram, Alissa, Louzada, Martha, Song, Kevin, White, Darrell, Sebag, Michael, Stakiw, Julie, Reiman, Anthony, Aslam, Muhammad, Bergstrom, Debra, Kotb, Rami, Kaedbey, Rayan, Gul, Engin, Reece, Donna, Venner, Christopher P.
Publicado 2023

Correction: Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis

por McCurdy, Arleigh, Mian, Hira, LeBlanc, Richard, Jimenez-Zepeda, Victor H., Su, Jiandong, Masih-Khan, Esther, Visram, Alissa, Louzada, Martha, Song, Kevin, White, Darrell, Sebag, Michael, Stakiw, Julie, Reiman, Anthony, Aslam, Muhammad, Bergstrom, Debra, Kotb, Rami, Kaedbey, Rayan, Gul, Engin, Reece, Donna, Venner, Christopher P.
Publicado 2023

Efficacy of Daratumumab-Containing Regimens Among Patients With Multiple Myeloma Progressing on Lenalidomide Maintenance: Retrospective Analysis

por Mian, Hira, Eisfeld, Christine, Venner, Christopher P., Masih-Khan, Esther, Kardjadj, Moustafa, Jimenez-Zepeda, Victor H., Khandanpour, Cyrus, Lenz, Georg, McCurdy, Arleigh, Sebag, Michael, Song, Kevin, LeBlanc, Richard, White, Darrell, Stakiw, Julie, Reiman, Anthony, Louzada, Martha, Aslam, Muhammad, Kotb, Rami, Gul, Engin, Reece, Donna
Publicado 2022

Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group database

por Côté, Julie, LeBlanc, Richard, Mian, Hira, Chu, Michael P., McCurdy, Arleigh, Masih-Khan, Esther, Su, Jiandong, Jimenez-Zepeda, Victor H., Song, Kevin, Louzada, Martha, White, Darrell, Sebag, Michael, Reiman, Anthony, Stakiw, Julie, Kotb, Rami, Bergstrom, Debra, Aslam, Muhammad, Kaedbey, Rayan, Venner, Christopher P., Gul, Engin, Reece, Donna
Publicado 2023

Late versus early response and depth of response are associated with improved outcomes in patients with newly diagnosed multiple myeloma enrolled in the TOURMALINE‐MM2 trial

por Richardson, Paul G., Facon, Thierry, Venner, Christopher P., Bahlis, Nizar J., Offner, Fritz, White, Darrell, Karlin, Lionel, Benboubker, Lotfi, Voog, Eric, Yoon, Sung‐Soo, Suzuki, Kenshi, Shibayama, Hirohiko, Zhang, Xiaoquan, Villarreal, Miguel, Twumasi‐Ankrah, Philip, Labotka, Richard, Rifkin, Robert M., Lonial, Sagar, Kumar, Shaji K., Rajkumar, S. Vincent, Moreau, Philippe
Publicado 2023